GlassScriptPhysician profile
Kiet M Loc
NPI 1609041581
$19,036.16
in general payments reported to CMS, 2019-2025
62 companies · $5,521 in 2025
The $5,521 reported for 2025 was more than what 86% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $325 · 2021: $948 · 2022: $1,451 · 2023: $4,492 · 2024: $5,535 · 2025: $5,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,413.36 |
| Education | $134.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $2,217.58 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Abbvie INC. | $1,668.38 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $1,531.97 | 2023-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $1,455.27 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Argenx US, INC. | $922.17 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $776.40 | 2019-2025 | |
| Lundbeck LLC | $775.11 | 2021-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $716.82 | 2020-2025 | Kisunla, Emgality, Amyvid |
| Amgen INC. | $670.51 | 2019-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $637.97 | 2023-2025 | Xcopri |
| Eisai INC. | $597.40 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $591.00 | 2019-2025 | Ultomiris, Soliris, Koselugo |
| Emd Serono, INC. | $551.56 | 2019-2025 | Mavenclad |
| Octapharma USA, INC. | $522.94 | 2022-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Teva Pharmaceuticals USA, INC. | $466.57 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $325.10 | 2021-2025 | Hyqvia, Gammagard |
| Otsuka America Pharmaceutical, INC. | $313.79 | 2023-2025 | Rexulti |
| Allergan, INC. | $253.98 | 2019-2021 | |
| Mdd US Operations, LLC | $225.64 | 2021-2025 | Gocovri, Gocovri |
| Merz Pharmaceuticals, LLC | $207.32 | 2021-2025 | Xeomin, Inbrija |
| Csl Behring | $197.51 | 2019-2024 | Hizentra |
| Grifols USA, LLC | $189.03 | 2020-2025 | Gamunex-C |
| Amneal Pharmaceuticals LLC | $187.16 | 2022-2025 | Rytary, Crexont |
| Livanova USA, INC. | $186.06 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Janssen Biotech, INC. | $178.07 | 2025 | |
| Axsome Therapeutics, INC. | $176.22 | 2025 | Symbravo |
| Celgene Corporation | $150.58 | 2022-2025 | Zeposia |
| Tanabe Pharma America, INC. | $134.69 | 2019-2025 | Radicava |
| Novartis Pharmaceuticals Corporation | $134.55 | 2023-2025 | |
| Boston Scientific Corporation | $133.62 | 2019-2025 | General - Dbs |
| Kyowa Kirin, INC. | $125.73 | 2022-2024 | Nourianz |
| Horizon Therapeutics Plc | $124.89 | 2022-2023 | Uplizna |
| Ani Pharmaceuticals, INC. | $120.83 | 2023-2024 | Purified Cortrophin Gel |
| Corium, LLC | $119.61 | 2022-2023 | Adlarity |
| Avion Pharmaceuticals | $118.03 | 2022-2023 | Dhivy |
| Adamas Pharmaceuticals, INC. | $117.04 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $115.79 | 2021-2025 | Wainua |
| Ipsen Biopharmaceuticals, INC | $108.88 | 2024 | Dysport |
| Genentech USA, INC. | $95.50 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Genzyme Corporation | $95.31 | 2019-2022 | |
| Averitas Pharma INC. | $77.27 | 2023-2024 | Qutenza |
| Alnylam Pharmaceuticals INC. | $71.20 | 2023-2024 | Amvuttra |
| Ge Healthcare | $70.61 | 2023-2024 | |
| Scilex Pharmaceuticals INC. | $68.28 | 2024-2025 | |
| Abbott Laboratories | $55.41 | 2022-2025 | Infinity |
| Biohaven Pharmaceuticals, INC. | $53.37 | 2021 | |
| Upsher-Smith Laboratories LLC | $48.68 | 2020-2021 | |
| Revance Therapeutics, INC. | $41.45 | 2024-2025 | Daxxify |
| Xeris Pharmaceuticals, INC. | $34.75 | 2022-2023 | Keveyis |
| Vanda Pharmaceuticals INC. | $32.67 | 2025 | Ponvory |
| Alfasigma USA, INC. | $32.40 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $25.98 | 2023 | Nuplazid |
| Impel Pharmaceuticals LLC | $25.80 | 2025 | Trudhesa |
| Avanir Pharmaceuticals, INC. | $24.24 | 2019 | |
| Vertical Pharmaceuticals, LLC | $23.23 | 2020 | |
| Insightec,INC | $22.26 | 2024 | Exablate |
| Biotronik INC. | $17.74 | 2023 | Biomonitor |
| Strongbridge US INC. | $17.73 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.99 | 2025 | Horizant |
| Arbor Pharmaceuticals, INC. | $16.93 | 2022 | |
| Impel Pharmaceuticals INC. | $16.74 | 2023 | Trudhesa |
| Dynasplint Systems INC. | $5.85 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiet Loc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.